360 High-Risk Vulnerability Immunization Tool V2.0 vs Mead Vulnerability Assessment (VA) & Management (VM): Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Mead Vulnerability Assessment (VA) & Management (VM): VA & VM service for identifying and managing security vulnerabilities. built by Mead Informatica. Core capabilities include External perimeter vulnerability assessment, Internal perimeter vulnerability assessment, Attack scenario simulation..

Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Mead Vulnerability Assessment (VA) & Management (VM) differentiates with External perimeter vulnerability assessment, Internal perimeter vulnerability assessment, Attack scenario simulation.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Mead Vulnerability Assessment (VA) & Management (VM) is developed by Mead Informatica. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Mead Vulnerability Assessment (VA) & Management (VM) serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools. Review the feature comparison above to determine which fits your requirements.